Literature DB >> 33234586

Outcomes and clinical practice in patients with COVID-19 admitted to the intensive care unit in Montréal, Canada: a descriptive analysis.

Stephen Su Yang1, Jed Lipes2, Sandra Dial2, Blair Schwartz2, Denny Laporta2, Evan Wong2, Craig Baldry2, Paul Warshawsky2, Patricia McMillan2, David Hornstein2, Michel de Marchie2, Dev Jayaraman2.   

Abstract

BACKGROUND: The coronavirus disease 2019 (COVID-19) pandemic is responsible for millions of infections worldwide, and a substantial number of these patients will be admitted to the intensive care unit (ICU). Our objective was to describe the characteristics, outcomes and management of critically ill patients with COVID-19 pneumonia at a single designated pandemic centre in Montréal, Canada.
METHODS: A descriptive analysis was performed on consecutive critically ill patients with COVID-19 pneumonia admitted to the ICU at the Jewish General Hospital, a designated pandemic centre in Montréal, between Mar. 5 and May 21, 2020. Complete follow-up data corresponding to death or discharge from hospital health records were included to Aug. 4, 2020. We summarized baseline characteristics, management and outcomes, including mortality.
RESULTS: A total of 106 patients were included in this study. Twenty-one patients (19.8%) died during their hospital stay, and the ICU mortality was 17.0% (18/106); all patients were discharged home or died, except for 4 patients (2 awaiting a rehabilitation bed and 2 awaiting long-term care). Twelve of 65 patients (18.5%) requiring mechanical ventilation died. Prone positioning was used in 29 patients (27.4%), including in 10 patients who were spontaneously breathing; no patient was placed on extracorporeal membrane oxygenation. High-flow nasal cannula was used in 51 patients (48.1%). Acute kidney injury was the most common complication, seen in 20 patients (18.9%), and 12 patients (11.3%) required renal replacement therapy. A total of 53 patients (50.0%) received corticosteroids.
INTERPRETATION: Our cohort of critically ill patients with COVID-19 had lower mortality than that previously described in other jurisdictions. These findings may help guide critical care decision-making in similar health care systems in further COVID-19 surges. Copyright 2020, Joule Inc. or its licensors.

Entities:  

Year:  2020        PMID: 33234586      PMCID: PMC7721255          DOI: 10.9778/cmajo.20200159

Source DB:  PubMed          Journal:  CMAJ Open        ISSN: 2291-0026


  33 in total

1.  APACHE II: a severity of disease classification system.

Authors:  W A Knaus; E A Draper; D P Wagner; J E Zimmerman
Journal:  Crit Care Med       Date:  1985-10       Impact factor: 7.598

Review 2.  Safety considerations with chloroquine, hydroxychloroquine and azithromycin in the management of SARS-CoV-2 infection.

Authors:  David N Juurlink
Journal:  CMAJ       Date:  2020-04-08       Impact factor: 8.262

3.  Care for Critically Ill Patients With COVID-19.

Authors:  Srinivas Murthy; Charles D Gomersall; Robert A Fowler
Journal:  JAMA       Date:  2020-04-21       Impact factor: 56.272

4.  Effects of early corticosteroid treatment on plasma SARS-associated Coronavirus RNA concentrations in adult patients.

Authors:  Nelson Lee; K C Allen Chan; David S Hui; Enders K O Ng; Alan Wu; Rossa W K Chiu; Vincent W S Wong; Paul K S Chan; K T Wong; Eric Wong; C S Cockram; John S Tam; Joseph J Y Sung; Y M Dennis Lo
Journal:  J Clin Virol       Date:  2004-12       Impact factor: 3.168

5.  Clinical course and outcome of 107 patients infected with the novel coronavirus, SARS-CoV-2, discharged from two hospitals in Wuhan, China.

Authors:  Dawei Wang; Yimei Yin; Chang Hu; Xing Liu; Xingguo Zhang; Shuliang Zhou; Mingzhi Jian; Haibo Xu; John Prowle; Bo Hu; Yirong Li; Zhiyong Peng
Journal:  Crit Care       Date:  2020-04-30       Impact factor: 9.097

Review 6.  The SOFA score-development, utility and challenges of accurate assessment in clinical trials.

Authors:  Simon Lambden; Pierre Francois Laterre; Mitchell M Levy; Bruno Francois
Journal:  Crit Care       Date:  2019-11-27       Impact factor: 9.097

7.  Clinical efficacy of hydroxychloroquine in patients with covid-19 pneumonia who require oxygen: observational comparative study using routine care data.

Authors:  Matthieu Mahévas; Viet-Thi Tran; Mathilde Roumier; Amélie Chabrol; Romain Paule; Constance Guillaud; Elena Fois; Raphael Lepeule; Tali-Anne Szwebel; François-Xavier Lescure; Frédéric Schlemmer; Marie Matignon; Mehdi Khellaf; Etienne Crickx; Benjamin Terrier; Caroline Morbieu; Paul Legendre; Julien Dang; Yoland Schoindre; Jean-Michel Pawlotsky; Marc Michel; Elodie Perrodeau; Nicolas Carlier; Nicolas Roche; Victoire de Lastours; Clément Ourghanlian; Solen Kerneis; Philippe Ménager; Luc Mouthon; Etienne Audureau; Philippe Ravaud; Bertrand Godeau; Sébastien Gallien; Nathalie Costedoat-Chalumeau
Journal:  BMJ       Date:  2020-05-14

8.  COVID-19 and the US response: accelerating health inequities.

Authors:  Nneoma E Okonkwo; Ugochi T Aguwa; Minyoung Jang; Iman A Barré; Kathleen R Page; Patrick S Sullivan; Chris Beyrer; Stefan Baral
Journal:  BMJ Evid Based Med       Date:  2020-06-03

9.  Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial.

Authors:  Jesús Villar; Carlos Ferrando; Domingo Martínez; Alfonso Ambrós; Tomás Muñoz; Juan A Soler; Gerardo Aguilar; Francisco Alba; Elena González-Higueras; Luís A Conesa; Carmen Martín-Rodríguez; Francisco J Díaz-Domínguez; Pablo Serna-Grande; Rosana Rivas; José Ferreres; Javier Belda; Lucía Capilla; Alec Tallet; José M Añón; Rosa L Fernández; Jesús M González-Martín
Journal:  Lancet Respir Med       Date:  2020-02-07       Impact factor: 30.700

10.  Clinical Features of 69 Cases With Coronavirus Disease 2019 in Wuhan, China.

Authors:  Zhongliang Wang; Bohan Yang; Qianwen Li; Lu Wen; Ruiguang Zhang
Journal:  Clin Infect Dis       Date:  2020-07-28       Impact factor: 9.079

View more
  3 in total

1.  Mortality trends and length of stays among hospitalized patients with COVID-19 in Ontario and Québec (Canada): a population-based cohort study of the first three epidemic waves.

Authors:  Yiqing Xia; Huiting Ma; David L Buckeridge; Marc Brisson; Beate Sander; Adrienne Chan; Aman Verma; Iris Ganser; Nadine Kronfli; Sharmistha Mishra; Mathieu Maheu-Giroux
Journal:  Int J Infect Dis       Date:  2022-04-25       Impact factor: 12.074

2.  Clinical characteristics, multiorgan dysfunction and outcomes of patients with COVID-19: a prospective case series.

Authors:  Kimia Honarmand; Kyle Fiorini; Debarati Chakraborty; Daniel Gillett; Karishma Desai; Claudio Martin; Karen J Bosma; Marat Slessarev; Ian M Ball; Tina Mele; Danielle LeBlanc; Sameer Elsayed; Alejandro Lazo-Langner; Mike J Nicholson; Robert Arntfield; John Basmaji
Journal:  CMAJ Open       Date:  2022-07-19

3.  Epidemiology, outcomes, and utilization of intensive care unit resources for critically ill COVID-19 patients in Libya: A prospective multi-center cohort study.

Authors:  Muhammed Elhadi; Ahmed Alsoufi; Abdurraouf Abusalama; Akram Alkaseek; Saedah Abdeewi; Mohammed Yahya; Alsnosy Mohammed; Mohammed Abdelkabir; Mohammed Huwaysh; Emad Amkhatirah; Kamel Alshorbaji; Samer Khel; Marwa Gamra; Abdulmueti Alhadi; Taha Abubaker; Mohamed Anaiba; Mohammed Elmugassabi; Muhannud Binnawara; Ala Khaled; Ahmed Zaid; Ahmed Msherghi
Journal:  PLoS One       Date:  2021-04-30       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.